skip to main content

Yellow Card reporting — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

EasyAdverse Drug Reactions and Drug SafetyYellow Card reportingGPhC CRA

A patient develops suspected angioedema two days after starting lisinopril. They attended urgent care and the medicine was stopped. The pharmacist asks whether this should be reported. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: E — Submit a Yellow Card report for the serious suspected adverse reaction

Angioedema is a serious suspected adverse reaction and should be reported through the Yellow Card scheme. Causality does not need to be proven before reporting a suspicion. The PMR should be updated to prevent re-exposure. Restarting an ACE inhibitor after angioedema can be dangerous.

Reference: MHRA Yellow Card; BNF